Seroreactivity against glycolytic enzymes in inflammatory bowel disease

Inflammatory Bowel Diseases

Volumn 17, Issue 2, 2011, Pages 557-564

  Vermeulen, Nathalie ^a   Vermeire, Severine ^a   Arijs, Ingrid ^a   Michiels, Georges ^a   Ballet, Vera ^a   Derua, Rita ^a   Waelkens, Etienne ^a   Lommel, Leentje Van ^a   Schuit, Frans ^a   Rutgeerts, Paul ^a   Bossuyt, Xavier ^a  

^a UNIVERSITY HOSPITALS LEUVEN   (Belgium)

Author keywords

antigens; autoantibodies; gene expression; glycolytic enzymes; IBD basic research; inflammatory bowel disease; neutrophils

Indexed keywords

ALPHA ENOLASE; AUTOANTIBODY; FRUCTOSE BISPHOSPHATE ALDOLASE; FRUCTOSE BISPHOSPHATE ALDOLASE A; GLYCOLYTIC ENZYME; HYPOXIA INDUCIBLE FACTOR 1; MALATE DEHYDROGENASE; MESSENGER RNA; PHOSPHOGLYCERATE MUTASE; PYRUVATE KINASE; TRIOSEPHOSPHATE ISOMERASE; UNCLASSIFIED DRUG;

ARTICLE; COLON BIOPSY; CONTROLLED STUDY; CROHN DISEASE; ENTERITIS; GENE EXPRESSION; GRANULOCYTE; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOREACTIVITY; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; PROTEOMICS; ULCERATIVE COLITIS; UPREGULATION;

ANTIBODIES, ANTINEUTROPHIL CYTOPLASMIC; BIOLOGICAL MARKERS; BLOTTING, WESTERN; CASE-CONTROL STUDIES; COLITIS, ULCERATIVE; CROHN DISEASE; ELECTROPHORESIS, GEL, TWO-DIMENSIONAL; ENZYME-LINKED IMMUNOSORBENT ASSAY; GENE EXPRESSION PROFILING; GLYCOLYSIS; HUMANS; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; PROTEOME; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; SPECTROMETRY, MASS, MATRIX-ASSISTED LASER DESORPTION-IONIZATION;

EID: 78651341982     PISSN: 10780998     EISSN: 15364844     Source Type: Journal    
DOI: 10.1002/ibd.21388     Document Type: Article

References (34)

1. Lennard-Jones JE,. Classification of inflammatory bowel disease. Scand J Gastroenterol. 1989; 24: 2-6.
2. Sartor RB,. Current concepts of the etiology and pathogenesis of ulcerative colitis and Crohn's disease. Gastroenterol Clin North Am. 1995; 24: 475-507.
3. Kallenberg CG, Brouwer E, Weening JJ, et al. Anti-neutrophil cytoplasmic antibodies: current diagnostic and pathophysiological potential. Kidney Int. 1994; 46: 1-15.
4. Falk RJ, Jennette JC,. Anti-neutrophil cytoplasmic autoantibodies with specificity for myeloperoxidase in patients with systemic vasculitis and idiopathic necrotizing and crescentic glomerulonephritis. N Engl J Med. 1988; 318: 1651-1657.
5. Bossuyt X,. Serologic markers in inflammatory bowel disease. Clin Chem. 2006; 52: 171-181.
6. Abad E, Tural C, Mirapeix E, et al. Relationship between ANCA and clinical activity in inflammatory bowel disease: variation in prevalence of ANCA and evidence of heterogeneity. J Autoimmun. 1997; 10: 175-180.
7. Huang X, Miller W,. A time-efficient, linear-space local similarity algorithm. Adv Appl Math. 1991; 12: 337-357.
8. Arijs I, Li K, Toedter G, et al. Mucosal gene signatures to predict response to infliximab in patients with ulcerative colitis. Gut. 2009; 58: 1612-1619.
9. Mole DR, Blancher C, Copley RR, et al. Genome-wide association of hypoxia-inducible factor (HIF)-1{alpha} and HIF-2{alpha} DNA binding with expression profiling of hypoxia-inducible transcripts. J Biol Chem. 2009; 284: 16767-16775.
10. Levene PA, Meyer GM,. The action of leucocytes on glucose. J Biol Chem. 1912; 11: 361-370.
11. Lewis JS, Lee JA, Underwood JC, et al. Macrophage responses to hypoxia: relevance to disease mechanisms. J Leukoc Biol. 1999; 66: 889-900.
12. Mor F, Izak M, Cohen IR,. Identification of aldolase as a target antigen in Alzheimer's disease. J Immunol. 2005; 175: 3439-3445.
13. Lu F, Xia Q, Ma Y, et al. Serum proteomic-based analysis for the identification of a potential serological marker for autoimmune hepatitis. Biochem Biophys Res Commun. 2008; 367: 284-290.
14. Vermeulen N, Arijs I, Joossens S, et al. Anti-alpha-enolase antibodies in patients with inflammatory bowel disease. Clin Chem. 2008; 54: 534-541.
15. Moodie FD, Leaker B, Cambridge G, et al. Alpha-enolase: a novel cytosolic autoantigen in ANCA positive vasculitis. Kidney Int. 1993; 43: 675-681.
16. Pratesi F, Moscato S, Sabbatini A, et al. Autoantibodies specific for alpha-enolase in systemic autoimmune disorders. J Rheumatol. 2000; 27: 109-115.
17. Moscato S, Pratesi F, Sabbatini A, et al. Surface expression of a glycolytic enzyme, alpha-enolase, recognized by autoantibodies in connective tissue disorders. Eur J Immunol. 2000; 30: 3575-3584.
18. Saulot V, Vittecoq O, Charlionet R, et al. Presence of autoantibodies to the glycolytic enzyme alpha-enolase in sera from patients with early rheumatoid arthritis. Arthritis Rheum. 2002; 46: 1196-1201.
19. Mosca M, Chimenti D, Pratesi F, et al. Prevalence and clinico-serological correlations of anti-alpha-enolase, anti-C1q, and anti-dsDNA antibodies in patients with systemic lupus erythematosus. J Rheumatol. 2006; 33: 695-697.
20. Forooghian F, Adamus G, Sproule M, et al. Enolase autoantibodies and retinal function in multiple sclerosis patients. Graefes Arch Clin Exp Ophthalmol. 2007; 245: 1077-1084.
21. Orth T, Kellner R, Diekmann O, et al. Identification and characterization of autoantibodies against catalase and alpha-enolase in patients with primary sclerosing cholangitis. Clin Exp Immunol. 1998; 112: 507-515.
22. Roozendaal C, Zhao MH, Horst G, et al. Catalase and alpha-enolase: two novel granulocyte autoantigens in inflammatory bowel disease (IBD). Clin Exp Immunol. 1998; 112: 10-16.
23. Ritter K, Brestrich H, Nellen B, et al. Autoantibodies against triosephosphate isomerase. A possible clue to pathogenesis of hemolytic anemia in infectious mononucleosis. J Exp Med. 1990; 171: 565-570.
24. Ritter K, Kuhlencord A, Thomssen R, et al. Prolonged haemolytic anaemia in malaria and autoantibodies against triosephosphate isomerase. Lancet. 1993; 342: 1333-1334.
25. Ritter K, Uy A, Ritter S, et al. Hemolysis and autoantibodies to triosephosphate isomerase in a patient with acute hepatitis A virus infection. Scand J Infect Dis. 1994; 26: 379-382.
26. Ritter S, Schröder S, Uy A, et al. Haemolysis in hepatitis A virus infections coinciding with the occurrence of autoantibodies against triosephosphate isomerase and the reactivation of latent persistent Epstein-Barr virus infection. J Med Virol. 1996; 50: 272-275.
27. Kolln J, Ren HM, Da RR, et al. Triosephosphate isomerase- and glyceraldehyde-3-phosphate dehydrogenase-reactive autoantibodies in the cerebrospinal fluid of patients with multiple sclerosis. J Immunol. 2006; 177: 5652-5658.
28. Xiang Y, Sekine T, Nakamura H, et al. Proteomic surveillance of autoimmunity in osteoarthritis: identification of triosephosphate isomerase as an autoantigen in patients with osteoarthritis. Arthritis Rheum. 2004; 50: 1511-1521.
29. Kansy JW, Katsovich L, McIver KS, et al. Identification of pyruvate kinase as an antigen associated with Tourette syndrome. J Neuroimmunol. 2006; 181: 165-176.
30. Sutton CL, Kim J, Yamane A, et al. Identification of a novel bacterial sequence associated with Crohn's disease. Gastroenterology. 2000; 119: 23-31.
31. Targan SR, Landers CJ, Yang H, et al. Antibodies to CBir1 flagellin define a unique response that is associated independently with complicated Crohn's disease. Gastroenterology. 2005; 128: 2020-2028.
32. Ferrante M, Henckaerts L, Joossens M, et al. New serological markers in inflammatory bowel disease are associated with complicated disease behaviour. Gut. 2007; 56: 1394-1403.
33. Taylor CT, Colgan SP,. Hypoxia and gastrointestinal disease. J Mol Med. 2007; 85: 1295-1300.
34. Giatromanolaki A, Sivridis E, Maltezos E, et al. Hypoxia inducible factor 1alpha and 2alpha overexpression in inflammatory bowel disease. J Clin Pathol. 2003; 56: 209-213.